This work is licensed under a Creative Commons Attribution 4.0 International License.
Fowlicidin-1 (1-19)
General Information
DRACP ID DRACP03869
Peptide Name Fowlicidin-1 (1-19)
Sequence RVKRVWPLVIRTVIAGYNL
Sequence Length 19
UniProt ID Q6QLQ5
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C106H177N31O23
Absent amino acids CDEFHMQS
Common amino acids V
Mass 257501
Pl 12.23
Basic residues 4
Acidic residues 0
Hydrophobic residues 10
Net charge 4
Boman Index -1874
Hydrophobicity 49.47
Aliphatic Index 148.42
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 6990
Absorbance 280nm 388.33
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31473417
Title The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 13892
This work is licensed under a Creative Commons Attribution 4.0 International License.